HEPATIC FIBROSIS
Clinical trials for HEPATIC FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC FIBROSIS trials appear
Sign up with your email to follow new studies for HEPATIC FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a blood pressure drug reverse liver damage in hepatitis c?
Disease control CompletedThis study tested whether adding prazosin, a drug usually used for high blood pressure, to standard hepatitis C treatment could reduce liver scarring. 112 adults with chronic hepatitis C (genotype 1 or 4) and severe liver fibrosis took part. Researchers measured changes in liver …
Matched conditions: HEPATIC FIBROSIS
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Hidden pain in liver patients: a new study investigates
Knowledge-focused CompletedThis completed study looked at how often hospitalized patients with cirrhosis experience pain. Researchers asked 30 patients about their pain, its location, intensity, and whether it was chronic. The goal was to highlight an often-overlooked issue and encourage better pain care f…
Matched conditions: HEPATIC FIBROSIS
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Heart safety check for experimental liver drug
Knowledge-focused CompletedThis early-stage trial tested whether a single dose of hydronidone, an experimental drug for liver fibrosis, changes the heart's electrical activity (QTc interval) in 48 healthy Chinese adults. Participants received one of three doses or a placebo, and researchers measured how th…
Matched conditions: HEPATIC FIBROSIS
Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC